Urinary biomarker and histopathological evaluation of vancomycin and piperacillin-1 tazobactam nephrotoxicity in comparison with vancomycin in a rat model and a confirmatory 2 cellular model 3

assess

[1]  C. Edelstein,et al.  Biomarkers of drug-induced kidney toxicity. , 2019, Therapeutic drug monitoring.

[2]  G. Bochi,et al.  Urinary kidney injury molecule-1 in renal disease. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[3]  Yang Liu,et al.  Acute kidney injury associated with concomitant vancomycin and piperacillin/tazobactam administration: a systematic review and meta-analysis , 2018, International Urology and Nephrology.

[4]  Huijun Sun,et al.  OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam. , 2018, International journal of pharmaceutics.

[5]  E. Beckman.  Piperacillin-Tazobactam Plus Vancomycin Equals Acute Kidney Injury: Does It Add Up? , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[6]  R. Watkins,et al.  Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy—What Is the Clinician to Do? , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Daudon,et al.  Vancomycin-Associated Cast Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[8]  C. Ghossein,et al.  Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[9]  H. Cohen,et al.  Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and Vancomycin , 2017, Journal of pharmacy practice.

[10]  J. Rindone,et al.  Does Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity when Used with Vancomycin: A Meta-Analysis of Observational Trials. , 2017, Current drug safety.

[11]  Anil Gulati,et al.  Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats , 2016, Antimicrobial Agents and Chemotherapy.

[12]  O. Bamgbola.  Review of vancomycin-induced renal toxicity: an update , 2016, Therapeutic advances in endocrinology and metabolism.

[13]  M. Neely,et al.  An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity. , 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[14]  A. Lázaro,et al.  Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity , 2015, BioMed research international.

[15]  A. Kosaka,et al.  Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat , 2014, Kidney international.

[16]  E. Wijdicks,et al.  Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy , 2013, Critical Care.

[17]  M. Scheetz,et al.  Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae , 2013, Antimicrobial Agents and Chemotherapy.

[18]  Michael A Rose,et al.  A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. , 2012, American journal of physiology. Renal physiology.

[19]  S. Czasch,et al.  Evaluation of Novel Acute Urinary Rat Kidney Toxicity Biomarker for Subacute Toxicity Studies in Preclinical Trials , 2012, Toxicologic pathology.

[20]  T. Yano,et al.  Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis. , 2012, Free radical biology & medicine.

[21]  Z. Fox,et al.  Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial , 2012, BMJ Open.

[22]  C. Ghossein,et al.  Biopsy-Proven Acute Tubular Necrosis due to Vancomycin Toxicity , 2011, International journal of nephrology.

[23]  K. Pandher,et al.  Topic of Histopathology Blinding in Nonclinical Safety Biomarker Qualification Studies , 2010, Toxicologic pathology.

[24]  Joseph V Bonventre,et al.  Next-generation biomarkers for detecting kidney toxicity , 2010, Nature Biotechnology.

[25]  Amy G. Aslamkhan,et al.  Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury , 2010, Nature Biotechnology.

[26]  Frank D Sistare,et al.  Towards consensus practices to qualify safety biomarkers for use in early drug development , 2010, Nature Biotechnology.

[27]  T. Skopek,et al.  A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function , 2010, Nature Biotechnology.

[28]  Jie Liu,et al.  Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. , 2009, Toxicology and applied pharmacology.

[29]  J. Bonventre,et al.  Preclinical evaluation of novel urinary biomarkers of cadmium nephrotoxicity. , 2009, Toxicology and applied pharmacology.

[30]  WB Mattes,et al.  Translational Toxicology and the Work of the Predictive Safety Testing Consortium , 2009, Clinical pharmacology and therapeutics.

[31]  G. Drusano,et al.  Prospective Evaluation of the Effect of an Aminoglycoside Dosing Regimen on Rates of Observed Nephrotoxicity and Ototoxicity , 1999, Antimicrobial Agents and Chemotherapy.

[32]  P. Tulkens,et al.  Aminoglycosides: Nephrotoxicity , 1999, Antimicrobial Agents and Chemotherapy.

[33]  J. Shimada,et al.  Inhibition of the renal excretion of tazobactam by piperacillin. , 1994, The Journal of antimicrobial chemotherapy.

[34]  M. Morris,et al.  Evaluation of “True” Creatinine Clearance in Rats Reveals Extensive Renal Secretion , 1991, Pharmaceutical Research.

[35]  R. Zager.  Exogenous creatinine clearance accurately assesses filtration failure in rat experimental nephropathies. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  G. Todaro,et al.  Epithelioid and fibroblastic rat kidney cell clones: Epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation , 1978, Journal of cellular physiology.

[37]  J. Killander,et al.  Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man. , 1975, The Journal of urology.

[38]  Sarah C. Emerson,et al.  Imperfect gold standards for kidney injury biomarker evaluation. , 2012, Journal of the American Society of Nephrology : JASN.

[39]  D. Levine,et al.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[40]  G. Kaloyanides,et al.  Aminoglycoside nephrotoxicity. , 1980, Kidney international.